Project

Nephrolyx

Nephrolyx Logo
Keywords

Fast, accurate measurement of glomerular filtration rate is essential for kidney function management. Nephrolyx IVDx is the new gold standard to measure GFR.

Spin-Off

Project Website

1.7 million deaths per year are caused by Acute Kidney Injury (AKI) globally. AKI is a frequent clinical event occurring in up to 20 % of all hospital patients. Patients with AKI have a significantly higher risk of developing or exacerbating a chronic kidney disease. As of today, an early detection tool for AKI is not available. AKICHECK aims to close this gap of early detection with an easy-to-use tool for rapid and precise kidney function measurements.

Markus van der Giet
Markus van der Giet
(Charité)

Project Lead

Translating scientific expertise in kidney function measurements to clinical routine, AKICHECK utilizes a proprietary database, a protocol for contrast agent measurement, and a software to diagnose AKI within the first two to seven hours – reducing the time needed by over tenfold. AKICHECK is easy to integrate into today’s clinical workflow everywhere and, given low component costs, promises a step-changing improvement in both patient outcomes and healthcare system performance.

Team AKICHECK unites deep expertise in clinical medicine with focus on nephrology, biomedical and laboratory expertise, biostatistics and machine learning. The project spun off in 2022 as Nephrolytix GmbH to reach their aim to uncover the AKI blind spot.

DHA

Project Lead

Markus van der Giet

Nephrolyx (Spin-Off)

„The first phase of the BIH Accelerator program is focused on translating ideas and early-stage research results into potential marketable products. The short timeframe of this phase can certainly appear overly ambitious, but due to highly-concentrated and team-centered coaching, program participants are well-supported through all the essential steps that lead to the development of a prototype or product.“

Markus van der Giet

(Charité)